Therapy of Lymphoma/Leukemia with Monoclonal Antibodies

Helen E. Heslop

Anti-viral and antileukemic T-cell therapy as prophylaxis after HSCT

Leukaemia

Investigator from Dana–Farber Cancer Institute

Nursing Oncology Capacity Building through Fellowship Programs in Rwanda and Haiti

Non-Hodgkin lymphoma

Martha Lassiter

2012 Tata Memorial Hospital Bone Marrow Transplant Program in Kolkata, India

Hodgkin lymphoma

Hematology and hematologic malignancies

Christopher S Carlson

Monitoring disease progression in follicular lymphoma with next-gen sequencing

Non-Hodgkin lymphoma

Pathology

Martha Lassiter

Duke University Nursing Oncology Training Exchange with Tata Memorial Hospital

Hodgkin lymphoma Leukaemia Non-Hodgkin lymphoma

Corey Casper

Uganda Cancer Institute / Hutchinson Center Cancer Alliance (UCI/HCCA)

Hodgkin lymphoma Non-Hodgkin lymphoma

Effie W Petersdorf

Genetic Mechanisms of Survivorship Disparities after Unrelated HCT

Leukaemia

Brenda Marie Sandmaier

Alpha Radioimmunotherapy for Lymphoma Treatment

Non-Hodgkin lymphoma Hodgkin lymphoma

Talya Salz

Do cardiovascular risk factors modify the cardiotoxicity of lymphoma treatments?

Non-Hodgkin lymphoma Hodgkin lymphoma